Polaryx Therapeutics, Inc. (PLYX) › Operating Cash FlowPolaryx Therapeutics, Inc. (PLYX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2024: -$2.57M2025: -$3.94M-$3.94M2024Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$3.94M-53.3%2024-$2.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share